Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2017
Reporting Period: Preliminary financial results for the quarter and fiscal year ended January 1, 2017, presented at the J.P. Morgan Healthcare Conference.
Key Financial Metrics
This filing serves as a notice of a presentation regarding preliminary results. The text of this 8-K does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached transcript (Exhibit 99.1) and non-GAAP reconciliation (Exhibit 99.2), which are incorporated by reference but not detailed in the body of this report.
Material Changes
The filing does not explicitly detail material changes in financial performance versus prior periods within the text. It references a presentation where such comparisons were discussed. The primary material change disclosed in the text is a corporate governance amendment.
Guidance, Outlook, and Corporate Actions
- Financial Guidance: The filing references a "Reconciliation of non-GAAP financial guidance for fiscal year 2017" (Exhibit 99.2), indicating that forward-looking guidance was provided during the conference presentation, though specific targets are not listed in this document.
- Corporate Governance Change: Effective January 11, 2017, the Board amended the Company's Bylaws to implement a proxy access provision. This allows a stockholder (or group of up to 20) owning 3% or more of outstanding capital stock continuously for at least three years to nominate and include in proxy materials the greater of two directors or 20% of the Board.
- Management Commentary: Management presented preliminary results at the J.P. Morgan Healthcare Conference. The transcript is available on the Investor Relations website.
Investor Verification Checklist
- Review Exhibit 99.1 (Transcript) for specific preliminary revenue and earnings figures for the quarter and year ended January 1, 2017.
- Examine Exhibit 99.2 for the specific non-GAAP financial guidance targets for fiscal year 2017.
- Verify the full text of the Amended and Restated Bylaws (Exhibit 3.2) to understand the complete requirements for the new proxy access bylaw.
- Confirm the availability of the webcast on the Company's Investor Relations website, noted to remain available until April 11, 2017.